Finance

Lists
600789:SHA
Shandong Lukang Pharmaceutical Co Ltd
CN¥8.28
+1.60%
(+0.13) 1D
Oct 9, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600789...
Open
CN¥8.03
High
CN¥8.40
Low
CN¥7.91
Mkt. cap
8.65B
Avg. vol.
28.86M
Volume
113.85M
Dividend
0.60%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jul 15, 2026
P/E ratio
57.72
52-wk high
CN¥10.89
52-wk low
CN¥6.48
EPS
CN¥0.14
Shares outstanding
677.10M
No. of employees
6K
Open
CN¥8.03
High
CN¥8.40
Low
CN¥7.91
Mkt. cap
8.65B
Avg. vol.
28.86M
Volume
113.85M
Dividend
0.60%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jul 15, 2026
P/E ratio
57.72
52-wk high
CN¥10.89
52-wk low
CN¥6.48
EPS
CN¥0.14
Shares outstanding
677.10M
No. of employees
6K
News stories
From web sources and news partners
About Shandong Lukang Pharmaceutical Co Ltd
CEO-
Employees6.47K
Founded1966
Headquarters-
SectorPharmaceutical industry
Websitelkpc.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.47B
1.14B
1.62B
1.62B
Cost of goods sold
1.13B
918.75M
1.27B
1.27B
Cost of revenue
1.13B
918.75M
1.27B
1.27B
Research and development expenses
82.71M
78.26M
64.32M
78.32M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
167.90M
202.59M
169.89M
173.82M
Operating expense
224.11M
308.76M
241.39M
270.30M
Total operating expenses
1.35B
1.23B
1.51B
1.54B
Operating income
115.74M
-85.74M
103.13M
79.44M
Other non operating income
9.51M
-6.76M
-11.08M
3.14M
EBT including unusual items
43.40M
-25.13M
66.74M
89.18M
EBT excluding unusual items
104.27M
-105.95M
80.99M
55.84M
Income tax expense
7.43M
9.58M
10.20M
-275.03K
Effective tax rate
17.12%
-38.14%
15.29%
-0.31%
Other operating expenses
-23.55M
34.36M
-98.01K
16.90M
Net income
34.36M
-28.89M
53.25M
84.89M
Net profit margin
2.34%
-2.53%
3.29%
5.24%
Earnings per share
-
-
-
-
Interest and investment income
2.22M
3.18M
2.44M
2.71M
Interest expense
-15.83M
-16.52M
-13.50M
-11.84M
Net interest expenses
-13.61M
-13.35M
-11.06M
-9.13M
Depreciation and amortization charges
-
-
-
-
EBITDA
215.49M
21.61M
210.49M
189.00M
Gain or loss from assets sale
54.69K
-168.15K
-
-1.95K
AI content may include mistakes. Learn more
Google apps